UNITED STATES
22nd Century Group announced that James A. Mish has been appointed chief executive officer, effective June 22, and John Franzino has been appointed chief financial officer.
Mish brings extensive global executive leadership experience in science-driven organizations with a recent focus on the development, manufacturing, and commercialization of active pharmaceutical ingredients (“API”), including cannabinoids, and related consumer products. He has an outstanding track record of delivering profitable growth at both privately held and publicly traded companies.
Prior to joining 22nd Century, Mish served as c.e.o of Noramco, a global leader in the production of controlled substances for the pharmaceutical industry, and Purisys, a synthetic cannabinoid API, ingredients and solutions provider to pharmaceutical and consumer products companies.
Prior to joining 22nd Century, Franzino served as chief financial officer of the West Point Association of Graduates. Additionally, he has extensive strategic financial leadership experience serving as vice president of finance and controller at Bard College; as c.f.o. of Santa Fe Natural Tobacco Company, a subsidiary of Reynolds American, Inc.; and as c.f.o. of Labatt USA.